Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1351813-70-1

7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine is a heterocyclic chemical compound with the molecular formula C7H3BrClN3. It features a pyrazolo[4,3-b]pyridine backbone and has bromine and chlorine substituents on the 7th and 5th carbon atoms, respectively.

1351813-70-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1351813-70-1 Structure

  • Basic information

    1. Product Name: 7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine
    2. Synonyms:
    3. CAS NO:1351813-70-1
    4. Molecular Formula:
    5. Molecular Weight: 232.467
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1351813-70-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine(CAS DataBase Reference)
    10. NIST Chemistry Reference: 7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine(1351813-70-1)
    11. EPA Substance Registry System: 7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine(1351813-70-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1351813-70-1(Hazardous Substances Data)

1351813-70-1 Usage

Uses

Used in Pharmaceutical Industry:
7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine is used as a potential candidate in the development of new drugs and agrochemicals due to its unique chemical structure and reactivity.
Used in Research:
7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine is used as a building block for the synthesis of other heterocyclic compounds, contributing to the advancement of chemical research and the creation of novel compounds with various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1351813-70-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,1,8,1 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1351813-70:
(9*1)+(8*3)+(7*5)+(6*1)+(5*8)+(4*1)+(3*3)+(2*7)+(1*0)=141
141 % 10 = 1
So 1351813-70-1 is a valid CAS Registry Number.

1351813-70-1Relevant articles and documents

MACROCYCLES AS PDE1 INHIBITORS

-

, (2019/06/30)

The present invention provides macrocycles of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

-

, (2019/07/19)

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

-

, (2019/07/10)

The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

-

, (2019/07/19)

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

-

, (2018/09/25)

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

FUSED PYRAZOLE DERIVATIVES AS JAK INHIBITORS

-

, (2018/04/11)

Novel fused pyrazole derivatives of Formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1351813-70-1